FAU to host potentially groundbreaking drug trial for Alzheimer's-like disease
The double-blind trial will examine the effects of RVT-101, which stimulates the release of acetylcholine in the brain, on a total of 240 patients diagnosed with dementia with Lewy bodies, said Axovant officials. Results are expected in 2017, with the ...
Dementia vs Alzheimer's Disease
"Being involved in research makes me feel valued," says York woman with Alzheimer's
Sheffield MP backs new Alzheimer's Society campaign